These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20623996)

  • 1. Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia.
    Gonzalez S; Gondwe C; Tully DC; Minhas V; Shea D; Kankasa C; M'soka T; Wood C
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):795-803. PubMed ID: 20623996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of primary resistance mutations to HIV-1 entry inhibitors in therapy naive subtype C HIV-1 infected mother-infant pairs from Zambia.
    Guo H; Liu C; Liu B; Wood C; Kong X
    J Clin Virol; 2013 Sep; 58(1):233-9. PubMed ID: 23809473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia.
    Hamers RL; Siwale M; Wallis CL; Labib M; van Hasselt R; Stevens WS; Schuurman R; Wensing AM; Van Vugt M; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):95-101. PubMed ID: 20585262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.
    Liang EC; Sceats L; Bayless NL; Strauss-Albee DM; Kubo J; Grant PM; Furman D; Desai M; Katzenstein DA; Davis MM; Zolopa AR; Blish CA
    J Virol; 2014 Aug; 88(15):8629-39. PubMed ID: 24850730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Characterization of the Human Immunodeficiency Virus Type 1 in Women and Their Vertically Infected Children.
    Vaz SN; Giovanetti M; Rego FF; Oliveira Td; Danaviah S; Gonçalves ML; Alcantara LC; Brites C
    AIDS Res Hum Retroviruses; 2015 Oct; 31(10):1046-51. PubMed ID: 26200738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil.
    Cardoso LP; Stefani MM
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):943-50. PubMed ID: 19792869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relatively high prevalence of drug resistance among antiretroviral-naive patients from Henan, Central China.
    Li L; Sun B; Zeng H; Sun Z; Sun G; Yang R
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):160-4. PubMed ID: 23800338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya.
    Lihana RW; Khamadi SA; Lubano K; Mwangi J; Kinyua JG; Okoth VO; Lagat NJ; Okoth FA; Songok EM; Makokha EP
    AIDS Res Hum Retroviruses; 2010 Jul; 26(7):833-8. PubMed ID: 20624074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients.
    Abecasis AB; Martins A; Costa I; Carvalho AP; Diogo I; Gomes P; Camacho RJ;
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):803-5. PubMed ID: 21198411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia.
    Mulu A; Lange T; Liebert UG; Maier M
    BMC Infect Dis; 2014 Mar; 14():158. PubMed ID: 24655349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil.
    Sprinz E; Netto EM; Patelli M; Lima JS; Furtado JJ; da Eira M; Zajdenverg R; Madruga JV; Lewi DS; Machado AA; Pedro RJ; Soares MA
    AIDS Res Hum Retroviruses; 2009 Sep; 25(9):861-7. PubMed ID: 19689190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam.
    Phan TT; Ishizaki A; Phung DC; Bi X; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2010 Feb; 26(2):233-5. PubMed ID: 20156106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.